TherapeuticsMD Statistics Share Statistics TherapeuticsMD has 11.57M
shares outstanding. The number of shares has increased by 0.36%
in one year.
Shares Outstanding 11.57M Shares Change (YoY) 0.36% Shares Change (QoQ) 0.36% Owned by Institutions (%) 28.94% Shares Floating 11.34M Failed to Deliver (FTD) Shares 5,314 FTD / Avg. Volume 21.01%
Short Selling Information The latest short interest is 24.55K, so 0.21% of the outstanding
shares have been sold short.
Short Interest 24.55K Short % of Shares Out 0.21% Short % of Float 0.29% Short Ratio (days to cover) 1.26
Valuation Ratios The PE ratio is -4.55 and the forward
PE ratio is 6.32.
TherapeuticsMD's PEG ratio is
0.07.
PE Ratio -4.55 Forward PE 6.32 PS Ratio 5.63 Forward PS 1.4 PB Ratio 0.36 P/FCF Ratio 8.48 PEG Ratio 0.07
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for TherapeuticsMD.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.37,
with a Debt / Equity ratio of 0.26.
Current Ratio 2.37 Quick Ratio 2.37 Debt / Equity 0.26 Debt / EBITDA -2.41 Debt / FCF 6.13 Interest Coverage -501.05
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $1.76M Profits Per Employee $-2.18M Employee Count 1 Asset Turnover 0.05 Inventory Turnover n/a
Taxes Income Tax -31K Effective Tax Rate 1.32%
Stock Price Statistics The stock price has increased by -38.76% in the
last 52 weeks. The beta is 0.51, so TherapeuticsMD's
price volatility has been higher than the market average.
Beta 0.51 52-Week Price Change -38.76% 50-Day Moving Average 1.13 200-Day Moving Average 1.13 Relative Strength Index (RSI) 47.98 Average Volume (20 Days) 25,288
Income Statement In the last 12 months, TherapeuticsMD had revenue of 1.76M
and earned -2.18M
in profits. Earnings per share was -0.19.
Revenue 1.76M Gross Profit 1.76M Operating Income -4.76M Net Income -2.18M EBITDA -2.98M EBIT -3.49M Earnings Per Share (EPS) -0.19
Full Income Statement Balance Sheet The company has 5.06M in cash and 7.17M in
debt, giving a net cash position of -2.12M.
Cash & Cash Equivalents 5.06M Total Debt 7.17M Net Cash -2.12M Retained Earnings -951.82M Total Assets 38.5M Working Capital 8.8M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 1.17M
and capital expenditures 0, giving a free cash flow of 1.17M.
Operating Cash Flow 1.17M Capital Expenditures n/a Free Cash Flow 1.17M FCF Per Share 0.1
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of -270.3% and -123.85%.
Gross Margin 100% Operating Margin -270.3% Pretax Margin -133.05% Profit Margin -123.85% EBITDA Margin -169.39% EBIT Margin -270.3% FCF Margin 66.44%
Dividends & Yields TXMD does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for TXMD.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on May 9, 2022. It was a
backward
split with a ratio of 1:50.
Last Split Date May 9, 2022 Split Type backward Split Ratio 1:50
Scores Altman Z-Score -33.74 Piotroski F-Score 4
